Nanjing Haijing Pharmaceutical

Nanjing Haijing Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, manufacturing, and commercialization of chemical drugs. Established in 2002 and headquartered in the Nanjing High-tech Zone, the company focuses on high-end generic medications and improved new drugs (Class 2) across several therapeutic areas, including cardiovascular, digestive, respiratory, and anti-infective systems. Nanjing Haijing operates modern GMP-certified manufacturing facilities and maintains a robust portfolio of approved products such as amlodipine besylate and rabeprazole sodium. The company is recognized as a High-tech Enterprise in Jiangsu Province, emphasizing quality control and technical innovation in drug formulation. Their business model integrates R&D with large-scale production to serve the domestic Chinese healthcare market.